rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Bal Pharma Ltd.

524824 BALPHARMA Group (B)

22 Jul,15:29
112.55
-0.15 (-0.13%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Bal Pharma Ltd.

BUYSELL

321 112.70 114.75 - 111.60 132.20 - 81.50 177.83
NSE | BSE

Bal Pharma Ltd.

BALPHARMA

22 Jul,15:40
112.68
-0.11 (-0.10%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Bal Pharma Ltd.

BUYSELL

13,175 112.79 115.00 - 111.60 132.45 - 81.20 14.98

News for Bal Pharma Ltd.

Uddhav Thackeray...
Uddhav Thackeray Claims Fadnavis Promised to Groom Aaditya as CM
Uddhav Thackeray claims Devendra Fadnavis promised to groom Aaditya Thackeray as CM in 2019, sparking a war of words between the two leaders. Fadnavis denies the claim, calling it 'delirious'.
Apr 21, 2024 08:26
Uddhav Thackeray:...
Uddhav Thackeray: Fadnavis Promised to Groom Aaditya as CM
Shiv Sena (UBT) leader Uddhav Thackeray claims Devendra Fadnavis promised to groom his son Aaditya as CM in 2019. Fadnavis denies the claim, calling Thackeray 'delirious'.
Apr 20, 2024 22:49
BJP Never Faced...
BJP Never Faced Split, Focused on Ideology: Fadnavis
Maharashtra Deputy CM Devendra Fadnavis asserts that BJP's ideology has kept it united, unlike other parties like Shiv Sena and NCP which have witnessed splits. He also emphasizes the party's...
Apr 06, 2024 12:13
BJP Never Faced...
BJP Never Faced Split, Focused on Ideology: Fadnavis
Maharashtra Deputy CM Devendra Fadnavis asserts BJP never faced internal divisions, highlighting the party's ideological foundation and its commitment to national interests. He also praises PM...
Apr 06, 2024 12:12
Delhi Economic...
Delhi Economic Survey: 11 Hospital Projects Underway
Delhi's Economic Survey reveals 11 new hospital construction projects underway, alongside hospital upgrades and data on birth, death, and dengue rates. Read more.
Mar 01, 2024 17:03

More News for Bal Pharma Ltd. »

(Rs. Crore)

Financial Results of Bal Pharma Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales338.54303.10280.37249.31170.67
Operating profit32.4426.0323.2026.326.26
Interest15.2412.1610.4011.9612.42
Gross profit20.5616.0319.2917.06-2.54
EPS (Rs)6.503.905.786.14-6.72

See more in Research Center »

News for Pharmaceuticals and health care

BigBloc...
BigBloc Construction Approves 1:1 Bonus Share Issue
BigBloc Construction's board has approved a 1:1 bonus share issue for shareholders, boosting share price and aiming to reward investors. The bonus issue is subject to shareholder approval at the...
Jul 22, 2024 15:32
Stallion India...
Stallion India IPO: Sebi Approves Fundraise
Stallion India Fluorochemicals, a supplier of refrigerants, has received Sebi's approval to float an IPO. The IPO includes a fresh issue of shares and an offer-for-sale component.
Jul 22, 2024 15:31
CRR Cut to Help...
CRR Cut to Help Banks Facing Low Deposit Growth: SBI MD
SBI MD Ashwini Tewari advocates for a CRR cut to help banks facing low deposit growth, citing the need for resources to fund economic activity. He highlights the pressure on banks due to the gap...
Jul 22, 2024 15:26
GST Reduces...
GST Reduces Logistics Cost: Economic Survey
India's Economic Survey highlights GST's role in reducing logistics costs, improving truck travel time, and boosting manufacturing. Learn about the impact on logistics performance and India's...
Jul 22, 2024 15:19
Economic Survey:...
Economic Survey: Remove Food From Inflation Targeting
India's Economic Survey suggests removing food from the inflation-targeting framework, arguing that higher food prices are often supply-induced. It proposes using coupons or direct cash transfers...
Jul 22, 2024 15:08

More News »

Top News

BigBloc...
BigBloc Construction Approves 1:1 Bonus Share Issue
BigBloc Construction's board has approved a 1:1 bonus share issue for shareholders, boosting share price and aiming to reward investors. The bonus issue is subject to shareholder approval at the...
Jul 22, 2024 15:32
Stallion India...
Stallion India IPO: Sebi Approves Fundraise
Stallion India Fluorochemicals, a supplier of refrigerants, has received Sebi's approval to float an IPO. The IPO includes a fresh issue of shares and an offer-for-sale component.
Jul 22, 2024 15:31
India's R&D Spending Lags Behind China, US: Eco Survey
India's R&D investment as a percentage of GDP remains low compared to China and the US, with private sector contribution also lagging, according to the Economic Survey 2023-24.
Jul 22, 2024 15:27
CRR Cut to Help...
CRR Cut to Help Banks Facing Low Deposit Growth: SBI MD
SBI MD Ashwini Tewari advocates for a CRR cut to help banks facing low deposit growth, citing the need for resources to fund economic activity. He highlights the pressure on banks due to the gap...
Jul 22, 2024 15:26
Retail Investor Surge in Stock Market: Economic Survey Cautions
India's Economic Survey warns of risks from rising retail investor participation in the stock market, highlighting potential for overconfidence and speculation. Read more.
Jul 22, 2024 15:23

More Top News »

Report Card

PE Ratios
17.34
EPS (Rs.)
6.50
Sales (Rs. Cr)
94.58
Face Value (Rs.)
10
Net Profit Margin (%)
2.02
Last Bonus
Last Dividend(%)
12
Return on Average Equity
6.47

Compare 'Bal Pharma Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,593.65
  • Compare
  • Divi's Laboratories Ltd.
  • 4,582.30
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,185.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,665.10
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,053.90
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,517.15
  • Compare
  • Max Healthcare Institute Ltd.
  • 933.40
  • Compare
  • Alkem Laboratories Ltd.
  • 5,265.25
  • Compare

Most Active

  • Change (Rs.)
  •  

Bal Pharma Ltd. performance snapshot

If you had invested Rs.  in Bal Pharma Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add Bal Pharma Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Bal Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close